AVALO THERAPEUTICS, INC. Income Taxes Paid
AVALO THERAPEUTICS, INC. (AVTX) reported Income Taxes Paid of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-29.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaid · last filed 2023-03-29
- AVALO THERAPEUTICS, INC. income taxes paid for the quarter ending 2021-12-31 was $0.00, a 100.00% decline year-over-year.
- AVALO THERAPEUTICS, INC. income taxes paid for the quarter ending 2021-09-30 was $0.00.
- AVALO THERAPEUTICS, INC. income taxes paid for the quarter ending 2021-06-30 was $0.00.
- AVALO THERAPEUTICS, INC. income taxes paid for the quarter ending 2021-03-31 was $0.00, a 100.00% decline year-over-year.
- AVALO THERAPEUTICS, INC. income taxes paid for fiscal 2022 was $0.00.
- AVALO THERAPEUTICS, INC. income taxes paid for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- AVALO THERAPEUTICS, INC. income taxes paid for fiscal 2020 was $474.00K, a 73.72% decline from fiscal 2019.
- AVALO THERAPEUTICS, INC. income taxes paid for fiscal 2019 was $1.80M, a 409.51% increase from fiscal 2018.
| Period end | Income Taxes Paid 3 month | Income Taxes Paid 6 month | Income Taxes Paid 9 month | Income Taxes Paid 12 month |
|---|---|---|---|---|
| 2022-12-31 | $0.00 10-K · filed 2023-03-29 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $0.00 derived: sum of 2 quarters · filed 2023-03-29 | $0.00 derived: sum of 3 quarters · filed 2023-03-29 | $0.00 10-K · filed 2023-03-29 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $0.00 derived: sum of 2 quarters · filed 2021-11-09 | $0.00 10-Q · filed 2021-11-09 | $158.00K derived: sum of 4 quarters · filed 2022-03-02 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-02 | $0.00 10-Q · filed 2021-08-02 | $158.00K derived: sum of 3 quarters · filed 2022-03-02 | $158.00K derived: sum of 4 quarters · filed 2022-03-02 |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-13 | $158.00K derived: sum of 2 quarters · filed 2022-03-02 | $158.00K derived: sum of 3 quarters · filed 2022-03-02 | $158.00K derived: sum of 4 quarters · filed 2022-03-02 |
| 2020-12-31 | $158.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-02 | $158.00K derived: sum of 2 quarters · filed 2022-03-02 | $158.00K derived: sum of 3 quarters · filed 2022-03-02 | $474.00K 10-K · filed 2022-03-02 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $0.00 derived: sum of 2 quarters · filed 2021-11-09 | $316.00K 10-Q · filed 2021-11-09 | $793.64K derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-02 | $316.00K 10-Q · filed 2021-08-02 | $793.64K derived: sum of 3 quarters · filed 2021-08-02 | $1.27M derived: sum of 4 quarters · filed 2021-08-02 |
| 2020-03-31 | $316.00K 10-Q · filed 2021-05-13 | $793.64K derived: sum of 2 quarters · filed 2021-05-13 | $1.27M derived: sum of 3 quarters · filed 2021-05-13 | $1.74M derived: sum of 4 quarters · filed 2021-05-13 |
| 2019-12-31 | $477.64K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-08 | $951.64K derived: sum of 2 quarters · filed 2021-03-08 | $1.43M derived: sum of 3 quarters · filed 2021-03-08 | $1.80M 10-K · filed 2021-03-08 |
| 2019-09-30 | $474.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $948.00K derived: sum of 2 quarters · filed 2020-11-09 | $1.33M 10-Q · filed 2020-11-09 | $1.68M derived: sum of 4 quarters · filed 2020-11-09 |
| 2019-06-30 | $474.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $852.02K 10-Q · filed 2020-08-06 | $1.21M derived: sum of 3 quarters · filed 2020-08-06 | $1.21M derived: sum of 4 quarters · filed 2020-08-06 |
| 2019-03-31 | $378.02K 10-Q · filed 2020-05-07 | $732.02K derived: sum of 2 quarters · filed 2020-05-07 | $732.02K derived: sum of 3 quarters · filed 2020-05-07 | $732.02K derived: sum of 4 quarters · filed 2020-05-07 |
| 2018-12-31 | $354.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-11 | $354.00K derived: sum of 2 quarters · filed 2020-03-11 | $354.00K derived: sum of 3 quarters · filed 2020-03-11 | $354.00K 10-K · filed 2020-03-11 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $0.00 derived: sum of 2 quarters · filed 2019-11-14 | $0.00 10-Q · filed 2019-11-14 | |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $0.00 10-Q · filed 2019-08-08 | ||
| 2018-03-31 | $0.00 10-Q · filed 2019-05-09 | |||
| 2017-12-31 | $540.00K 10-K · filed 2019-03-18 | |||
| 2016-12-31 | $0.00 10-K · filed 2018-04-02 | |||
| 2015-12-31 | $0.00 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |